HomeBREAKING NEWS Delhi AIIMS Among 3 Hospitals to Conduct Phase 2/3 Trials of Bharat Biotech’s Nasal Shot September 9, 2021 Share Facebook Twitter Pinterest WhatsApp Phase 2/3 clinical trials of the intranasal vaccine are likely to begin in the next two weeks as an application has been put to seek permission of the Ethics Committee. Previous articleAssam boat tragedy exposes safety lapses in India’s inland water transport systemNext article3 Men Gangrape Youth in Chhattisgarh, Police Register FIR Under Unnatural Offence Similar Articles Lakhimpur Kheri: Viral Video Shows Farmers Being Run Over by SUV, Oppn Questions Union Minister’s Claims BREAKING NEWS - October 5, 2021 The 29-second clip, which also shows another vehicle following the SUV, has raised questions on the version of the incident by Union minister Ajay... Karnataka: 3 Dead After Drinking Contaminated Water, 108 Show Similar Symptoms BREAKING NEWS - October 5, 2021 A total of six people have died in the last five weeks but the authorities have been able link just three of the deaths... Most Popular AMPC reforms: BJP digs out Siddaramaiah’s old letter India UAE Grow Bilateral Trade Amidst Worldwide Geopolitical Shifts Author Amish on why Bollywood doesn’t adapt ancient Sanskritic texts into films